The association between the IGF-I axis, thyroid hormones and cortical bone in patients with mild primary hyperparathyroidism

References

• Christiansen P. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. APMIS 2001;(Suppl.):1–52.
   PubMedGoogle Scholar
• Siilin H, Lundgren E, Mallmin H, Mellström D, Ohlsson C, Karlsson M, Orwoll E, Ljunggren O. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg 2011; 35:1266–72.
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989;4:283–91.
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton J 3rd.Fracture risk in primary hyperparathyroidism. J Bone Miner Res 2002;17(Suppl. 2):N103–7.
   Google Scholar
• Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000;321:598–602.
   PubMedGoogle Scholar
• Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 1999;25:589–95.
   PubMed Web of Science ®Google Scholar
• Lumachi F, Camozzi V, Ermani M, de Lotto F, Luisetto G. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study. Ann N Y Acad Sci 2007;1117:357–61.
   PubMed Web of Science ®Google Scholar
• VanderWalde LH, Liu IL, Haigh PI. Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg 2009;33:406–11.
   PubMed Web of Science ®Google Scholar
• Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J. Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 2004;136: 1281–8.
   PubMed Web of Science ®Google Scholar
• Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007; 92:3114–21.
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Mohan S, Sjögren K, Tivesten A, Isgaard J, Isaksson O, Jansson JO, Svensson J. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009;30:494–535.
   PubMed Web of Science ®Google Scholar
• Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997;278:419–24.
   PubMed Web of Science ®Google Scholar
• Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717–97.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Hwa V. The growth hormone cascade and its role in mammalian growth. Horm Res 2009;71(Suppl. 2):36–40.
   PubMedGoogle Scholar
• Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3864–70.
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87:2883–91.
   PubMed Web of Science ®Google Scholar
• Jogie-Brahim S, Feldman D, Oh Y. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev 2009;30:417–37.
   PubMed Web of Science ®Google Scholar
• Calò L, Castrignano R, Davis PA, Carraro G, Pagnin E, Giannini S, Semplicini A, D’Angelo A. Role of insulin- like growth factor-I in primary osteoporosis: a correlative study. J Endocrinol Invest 2000;23:223–7.
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 1997;12:1272–9.
   PubMed Web of Science ®Google Scholar
• Kim JG, Lee JY. Serum insulin-like growth factor binding protein profiles in postmenopausal women: their correlation with bone mineral density. Am J Obstet Gynecol 1996;174: 1511–7.
   PubMed Web of Science ®Google Scholar
• Garnero P, Sornay-Rendu E, Delmas PD. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 2000;355:898–9.
   PubMed Web of Science ®Google Scholar
• Paccou J, Dewailly J, Cortet B. Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine 2012;79:78–82.
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Mellström D, Carlzon D, Orwoll E, Ljunggren O, Karlsson MK, Vandenput L. Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 2011;26:865–72.
   PubMed Web of Science ®Google Scholar
• Svare A, Nilsen TI, Bjøro T, Forsmo S, Schei B, Langhammer A. Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. Eur J Endocrinol 2009;161:779–86.
   PubMed Web of Science ®Google Scholar
• Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;113:265–9.
   PubMed Web of Science ®Google Scholar
• Kung AW, Lorentz T, Tam SC. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol (Oxf) 1993;39:535–40.
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999;130: 750–8.
   PubMed Web of Science ®Google Scholar
• Murphy E, Glüer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2010;95:3173–81.
   PubMed Web of Science ®Google Scholar
• Sun L, Vukicevic S, Baliram R, Yang G, Sendak R, McPherson J, Zhu LL, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K, Zaidi M. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci USA 2008;105:4289–94.
   PubMed Web of Science ®Google Scholar
• Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O’Brien S, Schiavi SC, McPherson JM, Vukicevic S. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. J Bone Miner Res 2007;22:849–59.
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Khan AA, Potts JT Jr; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335–9.
   PubMed Web of Science ®Google Scholar
• Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab 2011;96: 2112–8.
   PubMed Web of Science ®Google Scholar
• Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E. GH secretion is impaired in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2002; 87:1961–4.
   PubMed Web of Science ®Google Scholar
• Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994;42: 140–4.
   PubMed Web of Science ®Google Scholar
• Danielsen CC, Flyvbjerg A. Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats. Bone 1996;19: 493–8.
   PubMed Web of Science ®Google Scholar
• Pye SR, Reid DM, Adams JE, Silman AJ, O’Neill TW. Radiographic features of lumbar disc degeneration and bone mineral density in men and women. Ann Rheum Dis 2006;65:234–8.
   PubMed Web of Science ®Google Scholar
• Higashi K, Morita M, Tajiri J, Shimada T, Umeda T, Sato T. Low serum reverse T3 levels in patients with primary hyperparathyroidism. Horm Metab Res 1987;19:325–7.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Hashizume K, Aizawa T, Ichikawa K, Yamada T. Thyrotropin secretion in patients with hyperparathyroidism or hypoparathyroidism: effect of serum calcium on thyrotropin release. J Clin Endocrinol Metab 1983;56:623–6.
   PubMed Web of Science ®Google Scholar
• Gillet C, Bergmann P, Francois D, Body JJ, Corvilain J. Low basal thyrotropin with normal thyroid function in primary hyperparathyroidism. Acta Endocrinol (Copenh) 1989;121: 638–42.
   PubMedGoogle Scholar
• Bergenfelz A, Ahrén B. Hyperthyroxinemia after surgery for primary hyperparathyroidism. Langenbecks Arch Chir 1994;379:178–81.
   PubMedGoogle Scholar
• Lindblom P, Valdemarsson S, Westerdahl J, Tennvall J, Bergenfelz A. Hyperthyroidism after surgery for primary hyperparathyroidism. Langenbecks Arch Surg 1999;384: 568–75.
   PubMed Web of Science ®Google Scholar
• Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134:561–8.
   PubMed Web of Science ®Google Scholar